Oppenheimer analyst Matthew Biegler initiates coverage on Homology Medicines (NASDAQ: FIXX) with a Perform rating.The analyst comments "Homology Medicines is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE